New targets for cancer chemotherapy.
作者信息
Murgo Anthony J, Dancey Janet, Eckhardt S Gail, Hidalgo Manuel, Arbuck Susan G, Zerivitz Kenn, Blaylock Barbara A
机构信息
Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd., Rockville, MD 20852, USA.
出版信息
Cancer Chemother Biol Response Modif. 2002;20:239-72.
PMID:12703208
Abstract
摘要
相似文献
1
New targets for cancer chemotherapy.
Cancer Chemother Biol Response Modif. 2002;20:239-72.
2
[Novel targets for cancer chemotherapy].
Gan To Kagaku Ryoho. 1996 Jan;23(2):191-201.
3
Preclinical and clinical development of novel agents that target the protein kinase C family.
Semin Oncol. 2006 Aug;33(4):466-78. doi: 10.1053/j.seminoncol.2006.04.009.
4
New targets for cancer chemotherapy.
Cancer Chemother Biol Response Modif. 2001;19:237-88.
5
Tumor cell metabolism: cancer's Achilles' heel.
Cancer Cell. 2008 Jun;13(6):472-82. doi: 10.1016/j.ccr.2008.05.005.
6
Telomerase inhibition, oligonucleotides, and clinical trials.
Oncogene. 2002 Jan 21;21(4):631-7. doi: 10.1038/sj.onc.1205063.
7
Telomerase as a target for cancer therapy.
Curr Opin Investig Drugs. 2005 Jun;6(6):605-10.
8
Intracellular signal transduction pathway proteins as targets for cancer therapy.
J Clin Oncol. 2005 Aug 10;23(23):5386-403. doi: 10.1200/JCO.2005.23.648. Epub 2005 Jun 27.
9
Issues and progress with protein kinase inhibitors for cancer treatment.
Nat Rev Drug Discov. 2003 Apr;2(4):296-313. doi: 10.1038/nrd1066.
10
Modulation of apoptosis signaling for cancer therapy.
Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):173-5. doi: 10.1007/s00005-006-0019-x. Epub 2006 May 2.
Zotero 插件